Skip to main content
Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
9.28
+4.01 (76.09%)
At close: Jul 2, 2024, 4:00 PM
9.60
+0.32 (3.45%)
After-hours: Jul 2, 2024, 7:59 PM EDT

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
 Current20232022202120202019
Market Capitalization
10419211014252-
Market Cap Growth
3.49%75.03%-23.01%174.06%--
Enterprise Value
1011868197440
PE Ratio
--3.41-4.33-9.83-9.51-
PB Ratio
-39.07-24.763.873.206.89-
P/FCF Ratio
-3.70-4.80-6.33-15.59-13.09-
P/OCF Ratio
-3.70-4.80-6.33-15.59-13.09-
EV/EBITDA Ratio
-2.69-3.31-3.21-6.68-8.04-0.48
EV/EBIT Ratio
-2.69-3.31-3.21-6.68-8.04-0.48
EV/FCF Ratio
-3.62-4.66-4.69-10.59-11.05-1.04
Debt / Equity Ratio
------0.06
Debt / EBITDA Ratio
------0.48
Debt / FCF Ratio
------1.05
Quick Ratio
0.641.343.6930.3313.960.37
Current Ratio
1.602.394.6830.5414.040.37
Return on Equity (ROE)
-1166.80%-565.10%-74.70%-40.20%-59.30%12.30%
Return on Assets (ROA)
-372.40%-326.80%-68.30%-38.90%-55.80%-169.70%
Return on Capital (ROIC)
1278.32%581.03%-90.07%-32.67%-88.06%19.88%
Earnings Yield
-45.85%-29.29%-23.10%-10.17%-10.51%-
FCF Yield
-34.12%-20.83%-15.79%-6.41%-7.64%-
Buyback Yield / Dilution
-29.65%-10.55%-7.03%-20.88%-2132.36%-1.81%
Total Shareholder Return
-29.65%-10.55%-7.03%-20.88%-2132.36%-1.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).